Olson K, Tkachuk L, Hanson J
Cross Cancer Institute, Alberta.
Clin Nurs Res. 1998 May;7(2):207-24. doi: 10.1177/105477389800700208.
This project addresses staff nurses' concerns about the development of hospital-acquired pressure sores in cancer patients. The Braden Scale and the National Pressure Sore Advisory Panel Staging System were pilot tested. The incidence of hospital-acquired pressure sores was 8% and a mean Braden score of 16 was sufficiently sensitive (82%) and specific (84%) for use with our patient population. Eighty-two percent (9/11) of the patients with a score of 16 on the Braden Scale developed a pressure sore that day. The model of pressure sore development constructed by Braden and Bergstrom (1987) was used to guide the development of a pressure sore prevention protocol. The pilot test of this protocol over 6 months showed no decline in the incidence of hospital-acquired pressure sores and a reduction in the sensitivity and specificity of the Braden Scale. Possible explanations for this finding and revisions to the protocol are suggested.
该项目解决了注册护士对癌症患者医院获得性压疮发生情况的担忧。对Braden量表和国家压疮咨询小组分期系统进行了试点测试。医院获得性压疮的发生率为8%,Braden平均评分为16,对于我们的患者群体而言,其敏感性(82%)和特异性(84%)足够高。Braden量表评分为16的患者中有82%(9/11)在当天发生了压疮。采用Braden和Bergstrom(1987年)构建的压疮发生模型来指导制定压疮预防方案。该方案在6个月内的试点测试表明,医院获得性压疮的发生率没有下降,Braden量表的敏感性和特异性有所降低。针对这一发现提出了可能的解释以及对方案的修订建议。